Objective: This study was performed to determine the effect of antenatal corticosteroid the interval between administration and delivery affect on neonatal outcomes.
Introduction
Preterm labor and preterm delivery are critical factors affecting neonatal morbidity and mortality (1) . The most common complication of premature birth is respiratory distress syndrome (RDS), which is caused by insufficient surfactant production in the immature fetal lung (2) . In 1972, Liggins reported that use of corticosteroids in the antenatal period improves the outcome of infants who deliver between 28 and 34 weeks of gestation (3) . During most of its gestational life, the fetus is exposed to very low levels of corticosteroids. A surge of corticosteroids in late pregnancy stimulates fetal lung surfactant production which is necessary for lung maturation. In preterm labor the neonate does not experience the late gestational steroid surge. These premature infants experience respiratory distress syndrome (RDS) and require mechanical lung ventilation (4) . Synthetic corticosteroids exhibit transplacental passage when administered to pregnant women because of the low affinity for maternal corticosteroid binding globulin (CBG) and poor breakdown by placental steroid metabolizing enzymes (5) . This treatment consists of corticosteroid administration for 48 hours, which is thought to stimulate innate surfactant production before delivery. Studies demonstrated improved respiratory outcomes among infants delivering within 7 days of corticosteroid therapy (5, 6) . Based on the original data of Liggins and Howie, where a positive effect of the corticosteroids was described up to 7 days, 2 R.N. Howie and G.C. Liggins, The New Zealand study of antepartum glucocorticoid treatment. In: P.M. Farrell, Editor, Lung development: biological and clinical perspectives Vol 2, Academic Press, New York (1982), pp. 255-265. the practice evolved to administer this treatment to undelivered at-risk patients on a weekly basis until delivery or maturity was reached (2) . Whereas the positive effect of a single course of antenatal corticosteroids for fetal lung maturation is proven, the usefulness of repetitive administration of corticosteroids is still under investigation and unclear (7) . Recent studies reported that the neonatal benefits do not diminish when delivery is beyond 7 days from the initial antenatal corticosteroids dose (2, 8) . Some studies documented no beneficial or even adverse effects of multiple antenatal corticosteroids courses (9) . In the controversy regarding some of these, some studies reported that a time interval of >14 days between the administration of antenatal corticosteroids and delivery is associated with an increased need for ventilatory support and surfactant use in neonates who deliver preterm (10, 11) . The objective of this study was to evaluate the effect of the time interval between the last corticosteroid treatment and delivery, and whether a prolonged interval (>7days) between antenatal corticosteroid therapy and delivery is associated with increased neonatal respiratory morbidity.
Materials and Methods
An observational study was designed and conducted on 104 preterm women who were between 28-34 weeks gestation and undergoing vaginal delivery after completing a single course of antenatal corticosteroid (Dexamethasone). The study was carried out in the obstetrics department of Shahid Sedughi hospital (University referral center) between 2006-2008. The adopted protocol was approved by the hospital research and ethics committee. The sample size estimation was based on studies with the hypothesis of need for respiratory support at gestational ages 26 to 34 weeks and using a Mann-Whitney test with a 0.05 two-sided significance level (n Query Advisor, Version 5.0). All women were interviewed individually by the researcher. Written informed consent was obtained from all the patients. The questionnaires were filled out for each patient at the beginning of the study and detailed information was collected on all deliveries by an obstetrics first year resident. Gestational age was based on the last menstrual period and/or ultrasonographic measurement of crown-rump length in early pregnancy and after 12 weeks gestation by ultrasonic measurement of fetal biparietal diameter and femur length. Individuals who reviewed the maternal charts were blinded to neonatal outcome data. Neonatal data were collected prospectively for infants admitted to the neonatal intensive care unit. Only neonates of mothers who received a complete course of antenatal corticosteroids were included. A single course was defined as Dexamethasone in a dosage of 6 mg given intramuscularly every 12 hours for two days (12) . Patients were grouped on the basis of the time interval between the administration of the first corticosteroid dose and delivery, < 2 days, 2-7 days and >7 days. Multiple gestations and neonates with congenital anomalies were excluded. Also the women with preeclampsia, severe maternal disease, receiving tocolytic agent, women with a diagnosis of preterm premature rupture of membranes, chorioamnionitis and cases in which delivery occurred after 34 weeks gestation were excluded. Neonates delivering within 7 days and after 7 days of initiation of corticosteroid treatment were compared with those delivering <2 days from treatment initiation in regard to the need for resuscitation and respiratory morbidities (including need for respiratory support by mechanical ventilation or continuous positive airway pressure for >24 hours). Data was analyzed with SPSS 11.5 software using the Student t test, Mann Whitney U test and χ 2 testing. P value <0.05 was considered statistically significant.
Results
One hundred and four women were identified who delivered between 2006 and 2008 at 28 -34 weeks gestation and had received a single course of antenatal corticosteroid therapy for the purpose of advancing pulmonary maturity. Of 104 neonates whose mothers received antenatal corticosteroid, 29 delivered <2 days, 41 delivered 2-7 days, and 34 delivered more than 7 days after the initial dose. The groups were similar in gestational age at delivery, maternal age, gender, and birth weight ( Table 1 ). The groups differed only in the interval from treatment to delivery, as expected by group assignment. Neonates delivering between 2-7 days of treatment had lower rates of resuscitation and ventilation. Infants delivering in under 2 days had more resuscitation and ventilation than those who delivered 2-7 days of treatment (20 (68.7%) vs 18 (43.9%) and 25 (83.1%) vs 21 (51.2%), p=0.01 and p=0.001 respectively) ( Table 2 ). Table 3 shows that both resuscitation and ventilation were significantly less in deliveries after 7 days compared with infants delivering <2 days of treatment (20 (68.7%) vs 17 (50%) and 25 (83.1%) vs 25 (73.5%) p<0.05), but the need to resuscitate was similar. Of 104 neonates whose mothers received a full course of antenatal corticosteroid, 35 (33.7%) were <32 weeks of gestation. Common odds ratios are presented for analyses that were stratified by gestational age. Of these, 10 neonates delivered <2 days, 17 neonates delivered 2-7 days and 8 neonates delivered after 7 days of antenatal corticosteroid exposure. Table 4 shows that differences between groups in respiratory outcomes were most evident for neonates at <32 weeks of gestational age. APGAR score in neonates delivering between 2-7 days of treatment was higher than the others, but this was not significant. Comparison of neonatal respiratory outcomes of <32 weeks of gestation who delivered after 7 days and 2-7 days after antenatal corticosteroid administration is given in Table 5 . Delivering after 7 days of corticosteroid administration have significantly better outcome.
Discussion
The most common complication of premature birth is respiratory distress syndrome (RDS), which is caused by insufficient surfactant production in the immature fetal lung (2) . Studies showed that antenatal corticosteroid therapy for fetal maturation is effective and reduces perinatal mortality and pulmonary and cerebral morbidity in preterm infants (7, 13) . The most effective timing for administration has not been established. Clinical evidence suggests that antenatal steroids are most effective in deliveries between 24 hours and 7 days after treatment, but that the benefits of treatment may begin to decrease after 7 days (2). It is unclear whether the beneficial effects of antenatal corticosteroid therapy diminish with time. Therefore, many clinicians prefer to repetitively administer corticosteroids to pregnant women who have not been delivered within 7 days of initial treatment and are still at high risk for preterm delivery. Some studies reported no beneficial or even adverse effects after multiple courses of antenatal corticosteroids (9, 14) . Our studies evaluated the effect of interval between a single dose of antenatal corticosteroid and delivery on neonatal outcome (need for resuscitation and ventilation for more than 24 hours), and showed that, when delivery occurred between 2 -7 after a single dose of corticosteroid, treatment can be more effective than <2 and >7 days. In this study, when delivery occurred in less than 2 days after the beginning of treatment, the need for resuscitation and ventilation were increased. Although in vitro experiments with human fetal lung explants have shown that the biochemical effects of steroid treatment also begins to decrease after 7 days (15), in our study only an increased need for ventilation for more than 24 hours was seen in those neonates delivering more than 7 days from treatment, but immediate resuscitation after birth was not similar to those delivering between 2-7 days. The results provide more evidence for other studies. Peaceman et al, reported similar results in 2005 (2). However, they used both dexamethasone or betamethasone in their study and these drugs can effect with different intervals. Waters in 2008 also reported similar results (11) . In contrast, Ring et al reported an increased risk for ventilatory support and surfactant use in neonates who delivered after 14 days following the administration of antenatal corticosteroids (10) . This may be prolonged more than 2 weeks between administration and deliveries in this study. Another study performed by Ay in Turkey, showed there was no statistically significant difference between groups of single and two courses of antenatal steroid therapy regarding the incidence of RDS and mechanical ventilator treatment (16) . We used a single course of corticosteroid treatment in our study because of controversy in other studies (in multiple or single course of corticosteroid treatment and their results). Banks et al reported that multiple courses of antenatal corticosteroids did not improve neonatal outcome, especially no reduction of the RDS was found. The outcome of infants delivered 1-6 days or 7-13 days after receiving antenatal corticosteroids was similar (14) ; and conversely, Throp et al could show that prolonged antenatal betamethasone therapy improved neonatal outcome and is not associated with higher risks of maternal adverse effects (18). This study compared 28-34 week gestational age infants. Although Ring et al reported an increased need for ventilatory support and surfactant use in neonates who deliver at >28 weeks of gestation in their study (H), our results showed that there were no difference in analyses <32 week of gestation and 32-34 weeks.
Conclusion
We found that theinterval between corticosteroid administration and delivery influences the incidence of need for resuscitation and ventilation. Infants delivering less than 2 days after corticosteroid exposure have a higher frequency of need for resuscitation and ventilation than those delivering between 2-7 days and after 7 days.
